1-6 of 6
Heinz A Duerk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response.

Mathias J. Rummel, MD, Norbert Niederle, Georg Maschmeyer, MD, G.-Andre Banat, MD, PhD, MBA, Ulrich von Grünhagen, MD, PhD, Chrisoph Losem, MD, PhD, Dorothea Kofahl-Krause, Gerhard Heil, MD, Manfred Welslau, Christina Balser, Ulrich Kaiser, MD, Eckhart Weidmann, Heinz A. Duerk, MD, PhD, Harald Ballo, Martina Beate Stauch, MD, Fritz Roller, Juergen Barth, Axel Hinke, Alexander C. Burchardt, MD, Wolfram Brugger
Journal: Blood
Blood (2012) 120 (21): 2724.
https://doi.org/10.1182/blood.V120.21.2724.2724
Published: 2012
Journal Articles

Therapy of Acquired Aplastic Anemia (AA) with Rabbit Antithymocyte Globulin (rATG): A Retrospective Analysis by the Working Group on Non-Malignant Disorders of Hematopoiesis of the German Society of Hematology and Oncology (DGHO),

Britta Höchsmann, MD, Christiane Neher, Ulrich Germing, MD, Janne Vehreschild, MD, Juliane Eggermann, MD, Dietrich Braumann, MD, Bernd Hertenstein, MD, Anke Franzke, MD, Karin Mayer, MD, Paul La Rosée, MD, Stefan Wilop, MD, Karl-Heinz Pflueger, MD, Hans-Josef Weh, MD, Bernd Gruhn, MD, Alfred Leipold, MD, Mark Ringhoffer, MD, Heinz A. Duerk, MD, Kumar Sinah, MD, Aristoteles Giagounidis, MD, Hubert Schrezenmeier, MD
Journal: Blood
Blood (2011) 118 (21): 3434.
https://doi.org/10.1182/blood.V118.21.3434.3434
Published: 2011
Journal Articles

Induction Therapy by Ara-C Plus Daunorubicin Versus Ara-C Plus Gemtuzumab Ozogamicin: Interim Analysis of a Randomized Phase II Trial of the SAL In Elderly Patients with Acute Myeloid Leukemia

Uta Brunnberg, Michael Mohr, Richard Noppeney, Heinz A. Duerk, Maria Cristina Sauerland, Carsten Müller-Tidow, Utz O Krug, Steffen Koschmieder, Torsten Kessler, Rolf M. Mesters, Christiane Schulz, Thomas Buchner, Gerhard Ehninger, Ulrich Dührsen, Hubert Serve, Wolfgang E. Berdel
Journal: Blood
Blood (2010) 116 (21): 335.
https://doi.org/10.1182/blood.V116.21.335.335
Published: 2010
Journal Articles

Bendamustine Plus Rituximab Is Superior in Respect of Progression Free Survival and CR Rate When Compared to CHOP Plus Rituximab as First-Line Treatment of Patients with Advanced Follicular, Indolent, and Mantle Cell Lymphomas: Final Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).

Mathias J Rummel, MD, PhD, Norbert Niederle, Georg Maschmeyer, Andre Banat, MD, MBA, Ulrich von Gruenhagen, MD, Christoph Losem, Gerhard Heil, Manfred Welslau, Christina Balser, Ulrich Kaiser, Harald Ballo, Eckhart Weidmann, Heinz A Duerk, Dorothea Kofahl-Krause, Fritz Roller, Juergen Barth, Dieter Hoelzer, MD, PhD, Axel Hinke, Wolfram Brugger
Journal: Blood
Blood (2009) 114 (22): 405.
https://doi.org/10.1182/blood.V114.22.405.405
Published: 2009
Journal Articles

Bortezomib, Intravenous Cyclophosphamide and Dexamethasone (VelCD) for Previously Untreated Multiple Myeloma: An Interim Analysis of the German DSMM XIa Trial

Stefan Knop, MD, Peter Liebisch, MD, Hannes Wandt, MD, Martin Kropff, MD, Volker Kunzmann, MD, Katja Weisel, MD, Daniel Franke, MD, Monika Engelhardt, MD, Lorenz H. Truemper, MD, PhD, Nikolaus Kroeger, MD, Burkhard Hennemann, MD, Michael Pfreundschuh, MD, PhD, Martin Gramatzki, MD, Bernd Metzner, MD, Christian Peschel, MD, Herbert G. Sayer, MD, PhD, Orhan Sezer, MD, Heinz A Duerk, MD, Bernd Hertenstein, MD, Hans-Guenther Mergenthaler, MD, Hella Gollasch, MD, Hans-Heinrich Wolf, MD, Georgia Schilling, MD, Claas Frohn, MD, Hermann Einsele, MD
Journal: Blood
Blood (2008) 112 (11): 2776.
https://doi.org/10.1182/blood.V112.11.2776.2776
Published: 2008
Journal Articles

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line-Treatment of Patients with Follicular, Indolent and Mantle Cell Lymphomas: Results of a Randomized Phase III Study of the Study Group Indolent Lymphomas (StiL)

Mathias J Rummel, Ulrich von Gruenhagen, Norbert Niederle, Harald Ballo, Eckhart Weidmann, Manfred Welslau, Gerhard Heil, Christina Balser, Heinz A Duerk, Martina Stauch, Dorothea Kofahl-Krause, Ulrich Kaiser, Wolfgang Knauf, Wolfram Brugger, MD
Journal: Blood
Blood (2008) 112 (11): 2596.
https://doi.org/10.1182/blood.V112.11.2596.2596
Published: 2008